Women in Sleep 2026 | May 15-16, 2026 | Austin, TX

The Women in Sleep Congress 2026 is a two-day live educational event dedicated to improving the recognition, diagnosis, and management of sleep disorders in female patients. The program explores how sleep disorders present differently in women across key life stages, including adolescence, pregnancy, perimenopause, and post-menopause.

Through expert-led presentations, panel discussions, and real-world case studies, the congress will translate evidence into practical clinical strategies that can be applied immediately in practice.

Learning Objectives

Upon completion of the educational activity, participants should be able to:

  • Interpret the effects of hormonal transitions across the female lifespan on sleep architecture, circadian rhythm, and disorder presentation to improve clinical recognition and treatment planning.

  • Evaluate gender-specific considerations in the pharmacologic treatment of sleep disorders, including metabolic, hormonal, and reproductive factors that impact safety and efficacy in female patients.

  • Apply age- and gender-informed diagnostic strategies to improve identification and early intervention for sleep disorders in adolescent girls and young women.

  • Develop structured clinical strategies to evaluate and manage sleep disturbances in perimenopausal and menopausal women, with balanced consideration of hormonal and non-hormonal treatment pathways.

  • Identify and address gender-specific presentation patterns of sleep-disordered breathing in women to improve diagnostic accuracy and treatment uptake.

Physicians

Physician Associates

Nurse Practitioners

Target Audience

This activity is designed for an audience of physicians, including Sleep Physicians/Fellows, Neurologists, Sleep Technologists, Physician Associates, Nurse Practitioners and other healthcare professionals.

Criteria for Success

A certificate of completion will be awarded based on the participant's attendance, completion of the online post test and evaluation/claim credit form. akhcme.com/sleep26. Please claim your credit by May 30, 2026. If you have questions about this CE activity, please contact AKH Inc at tbrignoni@akhcme.com.

Commercial Support

This activity is supported from an independent medical education grant from Harmony Biosciences Management, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

CE credit provided by AKH Inc., Advancing Knowledge in Healthcare.

Available credit:

support of improving patient care, this activity has been planned and implemented by AKH Inc., Advancing Knowledge in Healthcare and Clinical CME Group, LLC. AKH Inc., Advancing Knowledge in Healthcare is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 10.75 Interprofessional Continuing Education (IPCE) credit for learning and change.

AKH Inc., Advancing Knowledge in Healthcare designates this live activity for a maximum of 10.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AKH Inc., Advancing Knowledge in Healthcare has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 10.75 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

This activity has been planned and implemented in accordance with the Accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of AKH Inc., Advancing Knowledge in Healthcare and Clinical CME Group, LLC.  AKH Inc., Advancing Knowledge in Healthcare is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 030803. This activity is approved for 10.75 contact hour(s) (which includes 0 hour(s) of pharmacology).

 

*Hours subject to change